MERCK & COMPANY INC. news, videos and press releases - Page 2
For more news please use our advanced search feature.
MERCK & COMPANY INC. - More news...
MERCK & COMPANY INC. - More news...
-
Merck CEO: We talked about a tax code that helps job creation
- Biothera Pharmaceuticals Initiates Patient Dosing in Phase 2 Trial Investigating Imprime PGG and Merck’s KEYTRUDA® (pembrolizumab)
-
Merck
-
Merck
- Daktari Achieves Milestone in Its Merck HCV Collaboration
- Merck and Genea Open Centre of Excellence for Fertility
-
Merck CEO: Seeing ‘revolutionary change’ in the cure for cancer
-
Merck CEO on reforming Obamacare
- /C O R R E C T I O N -- Merck/
- /C O R R E C T I O N -- Merck/
- Merck Acquires BioControl to Strengthen Position in Food Safety Testing
- Merck Acquires BioControl to Strengthen Position in Food Safety Testing
- Interim Results from Phase 1b/2 Study Evaluating the Combination of Merck's KEYTRUDA® (pembrolizumab) and Eisai's HALAVEN® (eribulin mesylate) Injection in Metastatic Triple-Negative Breast Cancer Presented at 2016 San Antonio Breast Cancer Symposium
- Biothera Pharmaceuticals and Merck Further Expand Research Collaboration to Include Phase 2 Clinical Trial in Head and Neck Cancer
-
Merck CEO: Bringing Foreign Drugs Into The US Market Is A Dangerous Concept | CNBC
- Merck Expands Distribution Agreement with Roche
- Roche expands distribution alliance with the life science business of Merck KGaA, Darmstadt, Germany to include Kapa Biosystems qPCR and endpoint PCR Portfolios
- Merck Expands Distribution Agreement with Roche
-
Merck selects Alexandria Real Estate to develop research facility
- Merck Collaborates with Evotec for Faster Target Identification Solution
- Merck Collaborates with Evotec for Faster Target Identification Solution
- Emerald Medical Application's Dermacompare Technology Chosen as One of Four Start Up Technology Winners of Merck's Health Innovation Technology Scouts (HITS) Program
- OpGen Collaborates With Merck to Develop Novel Rapid Diagnostics and Informatics Tools to Combat Antibiotic Resistance
- UPDATE – HTG Molecular Diagnostics and Merck KGaA, Darmstadt, Germany, Enter Into a Master Companion Diagnostics Agreement
- HTG Molecular Diagnostics and Merck KGaA, Darmstadt, Germany, Enter Into a Master Companion Diagnostics Agreement
- Learn how to target a 20% return on First Majestic Silver, or get option-trade ideas on Alder Biopharmaceuticals, Mylan, Merck & Company Incorporated and Corrections Corporation of America or any stock you choose
- Vaccinex Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, to Evaluate the Combination of VX15/2503, and Avelumab in Non-Small Cell Lung Cancer
- Aralez Acquires United States And Canadian Rights To ZONTIVITY From Merck
-
Merck Discontinues Development of Osteoporosis Drug
-
Merck
